Collegium Pharmaceutical, Inc. (COLL) Operating cash flow 2016–2025
Collegium Pharmaceutical, Inc. (COLL) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$329.3MFY2025 · since FY2016: -$75.1M → $329.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $329.3M | +60.7% |
| FY2024 | $205.0M | -25.4% |
| FY2023 | $274.7M | +121.2% |
| FY2022 | $124.2M | +20.0% |
| FY2021 | $103.6M | +10.2% |
| FY2020 | $93.9M | +238.1% |
| FY2019 | $27.8M | -83.6% |
| FY2018 | $169.4M | +352.8% |
| FY2017 | -$67.0M | +10.7% |
| FY2016 | -$75.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More COLL financial trends
COLL RevenueCOLL Net incomeCOLL Net marginCOLL Gross profitCOLL Gross marginCOLL Operating incomeCOLL Operating marginCOLL Free cash flowCOLL Capital expendituresCOLL Return on equityCOLL Stock buybacksCOLL Dividends paidCOLL Total assetsCOLL Total liabilitiesCOLL Shareholders’ equityCOLL overview →